| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | 0.0076 | 0.8 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.0088 | 0.8 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.0064 | 0.8 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.0093 | 0.8 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.0072 | 0.8 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.006 | 0.9 |
| mRNA | epigallocatechin-3-monogallate | CTRPv2 | pan-cancer | AAC | -0.0071 | 0.9 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.0073 | 0.9 |
| mRNA | phloretin | CTRPv2 | pan-cancer | AAC | -0.0067 | 0.9 |